BIO-key International, Inc. (BKYI) Stock Forecast
BKYI analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 1 analysts
- Price target
- $20.00 average of analyst targets
- Upside to target
- +660.5% from the latest close
- Next earnings
- November 13, 2026 EPS estimate $-0.35
- 52-week range
- $1.65 – $10.30
BKYI analyst ratings
1 analystsNumber of analysts at each rating.
BKYI price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
BKYI earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.35 | −$0.35 | −$0.35 | −$1.49 | +76.4% | 1 |
| Current fiscal year (2026) | −$1.62 | −$1.62 | −$1.62 | — | — | 1 |
| Next fiscal year (2027) | $0.22 | $0.22 | $0.22 | −$1.62 | +113.6% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
BKYI revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.4M | $2.4M | $2.4M | +54.9% | 1 |
| Current fiscal year (2026) | $9.0M | $9.0M | $9.0M | — | 1 |
| Next fiscal year (2027) | $12.0M | $12.0M | $12.0M | +33.3% | 1 |
BKYI EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
BKYI revenue: reported and forecast
BKYI EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.70 | −$0.70 | −$0.70 | −$0.70 | −$0.35 | −50.0% | 1 up · 0 down |
| Current fiscal year (2026) | −$2.30 | −$2.30 | −$2.30 | −$2.30 | −$1.62 | −29.6% | 1 up · 0 down |
| Next fiscal year (2027) | $0.00 | $0.00 | $0.00 | $0.00 | $0.22 | — | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
BKYI earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; BKYI beat in 8 of 12.
What analysts expect from BKYI
1 analysts cover BIO-key International; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $20.00, 660.5% above the latest close of $2.63. Analysts expect earnings of −$1.62 per share for 2026. For 2027 the average estimate is $0.22 per share on revenue of $12.0 million. BIO-key International beat the EPS estimate in 8 of the last 12 quarters.
Related: BKYI income statement, BKYI key metrics, BKYI chart. See the BKYI stock overview for the latest quote and news.
BKYI forecast FAQ
What is BIO-key International's price target?
The average analyst price target for BIO-key International is $20.00, 660.5% above the latest close of $2.63.
Is BIO-key International a buy, hold or sell?
Of 1 analysts covering BIO-key International, 0 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is BIO-key International's EPS forecast?
Analysts forecast −$1.62 per share for 2026 (range −$1.62 to −$1.62); for 2027 the estimate is $0.22.
What is BIO-key International's revenue forecast?
The average revenue estimate for 2026 is $9.0 million; for 2027 it is $12.0 million.
When does BIO-key International report earnings?
BIO-key International is expected to report results for the quarter ending September 30, 2026 on November 13, 2026; the EPS estimate is $-0.35.
Does BIO-key International usually beat earnings estimates?
BIO-key International reported EPS at or above the analyst estimate in 8 of the last 12 quarters.